Ambrx Biopharma Cayman, Inc. reports

Location
10975 North Torrey Pines Road, La Jolla, CA
State of incorporation
Cayman Islands
Fiscal year end
December 31
Data updated at
7/19/2024, 08:54 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Feb 9, 2024
8-K Report | Data 8-K Oct 12, 2023 Oct 11, 2023
8-K Report | Data 8-K Oct 10, 2023 Oct 10, 2023
SC 13G Report SC 13G Oct 10, 2023
8-K Report | Data 8-K Oct 6, 2023 Oct 6, 2023
SC 13G Report SC 13G Sep 25, 2023
8-K Report | Data 8-K Sep 25, 2023 Sep 18, 2023
8-K Report | Data 8-K Sep 15, 2023 Sep 11, 2023
8-K Report | Data 8-K Sep 6, 2023 Sep 1, 2023
8-K Report | Data 8-K Aug 25, 2023 Aug 25, 2023
10-Q Report | Data 10-Q Aug 9, 2023 Jun 30, 2023
SC 13D/A Report AMBRX BIOPHARMA INC. Jun 28, 2023
8-K Report | Data 8-K Jun 28, 2023 Jun 27, 2023
8-K Report | Data 8-K Jun 8, 2023 Jun 8, 2023
SC 13D/A Report AMBRX BIOPHARMA INC. May 25, 2023
8-K Report | Data 8-K May 25, 2023 May 23, 2023
8-K Report | Data 8-K May 18, 2023 May 18, 2023
8-K Report | Data 8-K May 16, 2023 May 15, 2023
10-Q Report | Data 10-Q May 11, 2023 Mar 31, 2023
8-K Report | Data 8-K May 4, 2023 Apr 28, 2023
SC 13G/A Report Apr 27, 2023
8-K Report | Data 8-K Apr 10, 2023 Apr 10, 2023
10-K Report | Data 10-K Mar 30, 2023 Dec 31, 2022
SC 13G Report SC 13G Mar 16, 2023
SC 13G/A Report AMENDMENT NO. 3 Mar 13, 2023
8-K Report | Data 8-K Mar 13, 2023 Mar 13, 2023
SC 13D Report AMBRX BIOPHARMA INC. Mar 8, 2023
8-K Report | Data 8-K Mar 6, 2023 Mar 5, 2023
SC 13G/A Report Mar 3, 2023
SC 13G Report Mar 3, 2023
8-K Report | Data 8-K Mar 1, 2023 Mar 1, 2023
SC 13G Report SC 13G Feb 27, 2023
8-K Report | Data 8-K Feb 24, 2023 Feb 22, 2023
8-K Report | Data 8-K Feb 17, 2023 Feb 16, 2023
SC 13G/A Report SC 13G/A Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report AMBRX BIOPHARMA INC. Feb 14, 2023
SC 13G/A Report SC 13G/A Feb 13, 2023
SC 13G/A Report AMBRX BIOPHARMA INC. Feb 9, 2023
SC 13G/A Report Feb 9, 2023
8-K Report | Data 8-K Feb 6, 2023 Feb 6, 2023
8-K Report | Data 8-K Jan 30, 2023 Jan 27, 2023
SC 13G Report Dec 19, 2022
6-K Report 6-K Dec 16, 2022 Dec 16, 2022
6-K Report 6-K Dec 13, 2022 Dec 13, 2022
6-K Report 6-K Nov 1, 2022 Nov 1, 2022
6-K Report FORM 6-K Oct 18, 2022 Oct 18, 2022
6-K Report | Data 6-K Aug 29, 2022 Jun 30, 2022
6-K Report 6-K Aug 29, 2022 Aug 29, 2022
6-K Report FORM 6-K Aug 16, 2022 Aug 16, 2022
6-K Report 6-K Jul 5, 2022 Jul 5, 2022
6-K Report 6-K Jun 6, 2022 Jun 6, 2022
6-K Report 6-K May 17, 2022 May 17, 2022
20-F Report | Data 20-F Apr 26, 2022 Dec 31, 2021
6-K Report 6-K Apr 26, 2022 Apr 26, 2022
SC 13G/A Report Mar 10, 2022
SC 13G/A Report Feb 14, 2022
SC 13G/A Report SCHEDULE 13G/A Feb 11, 2022
SC 13G Report Feb 9, 2022
SC 13G Report SC 13G Feb 8, 2022
6-K Report 6-K Feb 7, 2022 Feb 7, 2022
SC 13G Report AMBRX BIOPHARMA INC. Jan 18, 2022
6-K Report 6-K Jan 4, 2022 Jan 4, 2022
6-K Report 6-K Dec 9, 2021 Dec 9, 2021
6-K Report 6-K Nov 22, 2021 Nov 22, 2021
6-K Report 6-K Nov 8, 2021 Nov 8, 2021
6-K Report FORM 6-K Oct 28, 2021 Oct 28, 2021
6-K Report 6-K Oct 28, 2021 Oct 28, 2021
6-K Report 6-K Oct 4, 2021 Oct 4, 2021
SC 13G Report SC 13G Jul 12, 2021
6-K Report 6-K Jul 2, 2021 Jun 30, 2021
SC 13G Report Jul 2, 2021
SC 13G Report SC 13G Jul 2, 2021